Content

Astellas case study in building commercial capability for Gene Therapy Manufacturing in Sanford, NC

Part of the BTEC Spring 2024 Seminar Series

Friday, Apr. 5, 2024
10:40–11:30 a.m. EST
BTEC room 135

A review of site selection, build, scale up, site-to-site transfer, and process comparability with a focus on XLMTM — a rare, serious, life-threatening neuromuscular disease causing extreme muscle weakness and respiratory failure.

Speaker

Don Mather, Ph.D.
Senior Vice President, Division Head, BioPharma Manufacturing
Astellas Pharma, Inc.